MLICM
ZEN

Metropolitan Life Insurance Company (MetLife)’s ZENDESK INC ZEN Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio ZEN Stock Details ZEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-7,916
Closed -$826K – 2779
2021
Q4 		$826K Sell
7,916
-62
-0.8% -$6.65K 0.01% 1108
2021
Q3 		$929K Sell
7,978
-168
-2% -$21.7K 0.01% 1015
2021
Q2 		$1.18M Sell
8,146
-246
-3% -$34.7K 0.02% 888
2021
Q1 		$1.11M Sell
8,392
-377
-4% -$54K 0.02% 866
2020
Q4 		$1.26M Sell
8,769
-75
-0.8% -$9.3K 0.02% 742
2020
Q3 		$910K Sell
8,844
-135
-2% -$12.6K 0.02% 800
2020
Q2 		$795K Buy
8,979
+1,149
+15% +$88.5K 0.01% 882
2020
Q1 		$501K Sell
7,830
-163
-2% -$12.7K 0.01% 1046
2019
Q4 		$613K Sell
7,993
-62
-0.8% -$4.54K 0.01% 1201
2019
Q3 		$587K Buy
8,055
+304
+4% +$25K 0.01% 1191
2019
Q2 		$690K Sell
7,751
-179
-2% -$15.4K 0.01% 1106
2019
Q1 		$674K Sell
7,930
-166
-2% -$12.2K 0.01% 1115
2018
Q4 		$473K Buy
8,096
+56
+0.7% +$3.23K 0.01% 1226
2018
Q3 		$571K Sell
8,040
-51
-0.6% -$3.26K 0.01% 1268
2018
Q2 		$441K Sell
8,091
-22,619
-74% -$1.2M 0.01% 1406
2018
Q1 		$1.47M Sell
30,710
-972
-3% -$40.3K 0.02% 710
2017
Q4 		$1.07M Sell
31,682
-34,163
-52% -$1.12M 0.01% 856
2017
Q3 		$1.92M Hold
65,845
– – 0.01% 953
2017
Q2 		$1.83M Buy
65,845
+9,937
+18% +$273K 0.01% 980
2017
Q1 		$1.57M Sell
55,908
-1,598
-3% -$41.4K 0.01% 1048
2016
Q4 		$1.22M Hold
57,506
– – 0.01% 1198
2016
Q3 		$1.77M Sell
57,506
-913
-2% -$27.1K 0.01% 1001
2016
Q2 		$1.54M Buy
58,419
+20,754
+55% +$501K 0.01% 1035
2016
Q1 		$788K Hold
37,665
– – 0.01% 1299
2015
Q4 		$996K Hold
37,665
– – 0.01% 1192
2015
Q3 		$742K Hold
37,665
– – 0.01% 1366
2015
Q2 		$837K Buy
+37,665
New +$866K 0.01% 1411
2015
Q1 		– Sell
-9,803
Closed -$239K – 2490
2014
Q4 		$239K Buy
9,803
+1,823
+23% +$42.9K ﹤0.01% 2281
2014
Q3 		$172K Sell
7,980
-6,124
-43% -$129K ﹤0.01% 2486
2014
Q2 		$245K Buy
+14,104
New +$236K ﹤0.01% 2359

Other funds holding ZEN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JP
Jana Partners New York $1.34B AUM 4.95% 1-Year Est. Return
MG
Meritage Group San Francisco, California $2.65B AUM 6.3% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s ZEN Position: Q1 2022 in Review

Metropolitan Life Insurance Company (MetLife) sold out of ZENDESK INC (ZEN) in Q1 2022, closing a stake of 7,916 shares — an estimated $826K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in ZEN in Q2 2014 and held it in 30 quarters. The position peaked at $1.92M in Q3 2017. 501 funds tracked by Wall St. Rank hold ZEN as of Q1 2022.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining ZENDESK INC position as of Q1 2022 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 7,916 ZENDESK INC shares in Q1 2022, an estimated $826K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in ZENDESK INC in Q2 2014 and held it in 30 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s ZENDESK INC position peaked at $1.92M in Q3 2017.
  • 501 funds tracked by Wall St. Rank held ZENDESK INC as of Q1 2022.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q1 2022, filed 12 May 2022.